https://www.selleckchem.com/pr....oducts/tak-243-mln24
6% versus 3.6%, =0.04). We showed a safe and effective clinical profile of NOACs among AF patients scheduled for electrical cardioversion in real-life setting. Patients on NOACs therapy showed a lower discontinuation rate compared to those on VKAs. We showed a safe and effective clinical profile of NOACs among AF patients scheduled for electrical cardioversion in real-life setting. Patients on NOACs therapy showed a lower discontinuation rate compared to those on VKAs. Slow-wave sleep (SWS) and obstructive sleep apnea (OSA) have